Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022

被引：9

作者：

Barth, Matthew ^{[1
]}

Xavier, Ana C. ^{[2
]}

Armenian, Saro ^{[3
]}

Audino, Anthony N. ^{[4
,5
]}

Blazin, Lindsay ^{[6
]}

Bloom, David ^{[7
]}

Chung, Jong ^{[8
]}

Davies, Kimberly ^{[9
]}

Ding, Hilda ^{[10
]}

Ford, James B. ^{[11
]}

Galardy, Paul J. ^{[12
]}

Hanna, Rabi ^{[13
,14
]}

Hayashi, Robert ^{[15
,16
]}

Lee-Miller, Cathy ^{[17
]}

Machnitz, Andrea Judit ^{[18
]}

Maloney, Kelly W. ^{[19
]}

Marks, Lianna ^{[20
]}

Martin, Paul L. ^{[21
]}

McCall, David ^{[22
]}

Pacheco, Martha ^{[23
]}

Reilly, Anne F. ^{[24
]}

Roshal, Mikhail ^{[25
]}

Song, Sophie ^{[26
]}

Weinstein, Joanna ^{[27
]}

Zarnegar-Lumley, Sara ^{[28
]}

McMillian, Nicole ^{[29
]}

Schonfeld, Ryan ^{[29
]}

Sundar, Hema ^{[29
]}

机构：

[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY 14203 USA

[2] Childrens Alabama ONeal Comprehens Canc Ctr UAB, Birmingham, AL USA

[3] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[4] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp, Columbus, OH 43210 USA

[5] Solove Res Inst, Columbus, OH USA

[6] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Bloomington, IN 47405 USA

[7] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[8] UC Davis Comprehens Canc Ctr, Davis, CA USA

[9] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA

[10] UC San Diego Moores Canc Ctr, UCSD Rady Childrens Hosp, San Diego, CA USA

[11] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[12] Mayo Clin Canc Ctr, Rochester, MN USA

[13] Univ Hosp Sedman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[14] Cleveland Clin Taussig Canc Inst, Cleveland, OH USA

[15] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[16] Washington Univ, Sch Med, St Louis, MO 63110 USA

[17] Univ Washington, Carbone Canc Ctr, Seattle, WA 98195 USA

[18] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[19] Univ Colorado, Canc Ctr, Childrens Hosp Colorado, Boulder, CO 80309 USA

[20] Stanford Canc Inst, Stanford, CA USA

[21] Duke Canc Ctr, Durham, NC USA

[22] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[23] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[24] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[25] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[26] UCLA Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[27] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[28] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[29] Natl Comprehens Canc Network, Washington, DC USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 11期

关键词：

NON-HODGKIN-LYMPHOMA; NUCLEAR ACCUMULATION; YOUNG-ADULTS; CHILDREN; FEATURES; GAINS; AMPLIFICATION; EXPRESSION; FREQUENT; THERAPY;

D O I：

10.6004/jnccn.2022.0057

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

引用

页码：1267 / 1275

页数：9

共 50 条

[31] Long-Term Survival in Aggressive B-Cell Lymphomas
Shao, Haipeng
Rastogi, Prerna
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142
[32] Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas
McBride, Amanda
Adams, Clare M.
Mitra, Ramkrishna
Eischen, Christine M.
BLOOD, 2020, 136
[33] Selective inhibitors of nuclear export in aggressive B-cell lymphomas
Chiappella, Annalisa
Corradini, Paolo
LANCET HAEMATOLOGY, 2020, 7 (07): : E500 - E501
[34] Classification of aggressive B-cell lymphomas News and open questions
Rosenwald, Andreas
Menter, Thomas
Dirnhofer, Stefan
PATHOLOGIE, 2023, 44 (03): : 166 - 172
[35] Aggressive B-cell lymphomas with a primary bone marrow presentation
Zamo, Alberto
Johnston, Peter
Attygalle, Ayoma D.
Laurent, Camille
Arber, Daniel A.
Fend, Falko
HISTOPATHOLOGY, 2020, 77 (03) : 369 - 379
[36] Current diagnostic and therapeutic standards in aggressive B-cell lymphomas
Friedrichs, Birte
Schmitz, Norbert
Lenz, Georg
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (03) : 151 - 154
[37] Anatomical Pattern of CNS Relapse in Aggressive B-cell Lymphomas
Okcu, Izel
Abeykoon, Jithma P.
Wang, Yucai
Moustafa, Muhamad Alhaj
Munoz, Javier L.
Johnston, Patrick B.
Witzig, Thomas E.
Kabat, Brian F.
Habermann, Thomas M.
Nowakowski, Grzegorz S.
Tun, Han W.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S472 - S473
[38] Genetic background and evolution of relapses in aggressive B-cell lymphomas
Juskevicius, Darius
Dirnhofer, Stephan
Tzankov, Alexandar
HAEMATOLOGICA, 2017, 102 (07) : 1139 - 1149
[39] Bptf determines oncogenic addiction in aggressive B-cell lymphomas
Laia Richart
Irene Felipe
Pilar Delgado
Mónica P. de Andrés
Jaime Prieto
Natalia del Pozo
Juan F. García
Miguel A. Piris
Almudena Ramiro
Francisco X. Real
Oncogene, 2020, 39 : 4884 - 4895
[40] Small molecule phenotypic targeting of aggressive B-cell lymphomas
Cardenas, Mariano G.
Teater, Matt R.
Calvo-Vidal, Nieves
Yang, Shao Ning
Glickman, J. F.
Melnick, Ari
Cerchietti, Leandro
CANCER RESEARCH, 2014, 74 (19)

← 1 2 3 4 5 →